Cargando…

Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics

BACKGROUND: Prognostic models based on individual patient characteristics can improve treatment decisions and outcome in the future. In many (radiomic) studies, small size and heterogeneity of datasets is a challenge that often limits performance and potential clinical applicability of these models....

Descripción completa

Detalles Bibliográficos
Autores principales: van Timmeren, Janna E., Carvalho, Sara, Leijenaar, Ralph T. H., Troost, Esther G. C., van Elmpt, Wouter, de Ruysscher, Dirk, Muratet, Jean-Pierre, Denis, Fabrice, Schimek-Jasch, Tanja, Nestle, Ursula, Jochems, Arthur, Woodruff, Henry C., Oberije, Cary, Lambin, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546238/
https://www.ncbi.nlm.nih.gov/pubmed/31158263
http://dx.doi.org/10.1371/journal.pone.0217536
_version_ 1783423514162757632
author van Timmeren, Janna E.
Carvalho, Sara
Leijenaar, Ralph T. H.
Troost, Esther G. C.
van Elmpt, Wouter
de Ruysscher, Dirk
Muratet, Jean-Pierre
Denis, Fabrice
Schimek-Jasch, Tanja
Nestle, Ursula
Jochems, Arthur
Woodruff, Henry C.
Oberije, Cary
Lambin, Philippe
author_facet van Timmeren, Janna E.
Carvalho, Sara
Leijenaar, Ralph T. H.
Troost, Esther G. C.
van Elmpt, Wouter
de Ruysscher, Dirk
Muratet, Jean-Pierre
Denis, Fabrice
Schimek-Jasch, Tanja
Nestle, Ursula
Jochems, Arthur
Woodruff, Henry C.
Oberije, Cary
Lambin, Philippe
author_sort van Timmeren, Janna E.
collection PubMed
description BACKGROUND: Prognostic models based on individual patient characteristics can improve treatment decisions and outcome in the future. In many (radiomic) studies, small size and heterogeneity of datasets is a challenge that often limits performance and potential clinical applicability of these models. The current study is example of a retrospective multi-centric study with challenges and caveats. To highlight common issues and emphasize potential pitfalls, we aimed for an extensive analysis of these multi-center pre-treatment datasets, with an additional (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan acquired during treatment. METHODS: The dataset consisted of 138 stage II-IV non-small cell lung cancer (NSCLC) patients from four different cohorts acquired from three different institutes. The differences between the cohorts were compared in terms of clinical characteristics and using the so-called ‘cohort differences model’ approach. Moreover, the potential prognostic performances for overall survival of radiomic features extracted from CT or FDG-PET, or relative or absolute differences between the scans at the two time points, were assessed using the LASSO regression method. Furthermore, the performances of five different classifiers were evaluated for all image sets. RESULTS: The individual cohorts substantially differed in terms of patient characteristics. Moreover, the cohort differences model indicated statistically significant differences between the cohorts. Neither LASSO nor any of the tested classifiers resulted in a clinical relevant prognostic model that could be validated on the available datasets. CONCLUSION: The results imply that the study might have been influenced by a limited sample size, heterogeneous patient characteristics, and inconsistent imaging parameters. No prognostic performance of FDG-PET or CT based radiomics models can be reported. This study highlights the necessity of extensive evaluations of cohorts and of validation datasets, especially in retrospective multi-centric datasets.
format Online
Article
Text
id pubmed-6546238
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-65462382019-06-17 Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics van Timmeren, Janna E. Carvalho, Sara Leijenaar, Ralph T. H. Troost, Esther G. C. van Elmpt, Wouter de Ruysscher, Dirk Muratet, Jean-Pierre Denis, Fabrice Schimek-Jasch, Tanja Nestle, Ursula Jochems, Arthur Woodruff, Henry C. Oberije, Cary Lambin, Philippe PLoS One Research Article BACKGROUND: Prognostic models based on individual patient characteristics can improve treatment decisions and outcome in the future. In many (radiomic) studies, small size and heterogeneity of datasets is a challenge that often limits performance and potential clinical applicability of these models. The current study is example of a retrospective multi-centric study with challenges and caveats. To highlight common issues and emphasize potential pitfalls, we aimed for an extensive analysis of these multi-center pre-treatment datasets, with an additional (18)F-fluorodeoxyglucose (FDG) positron emission tomography/computed tomography (PET/CT) scan acquired during treatment. METHODS: The dataset consisted of 138 stage II-IV non-small cell lung cancer (NSCLC) patients from four different cohorts acquired from three different institutes. The differences between the cohorts were compared in terms of clinical characteristics and using the so-called ‘cohort differences model’ approach. Moreover, the potential prognostic performances for overall survival of radiomic features extracted from CT or FDG-PET, or relative or absolute differences between the scans at the two time points, were assessed using the LASSO regression method. Furthermore, the performances of five different classifiers were evaluated for all image sets. RESULTS: The individual cohorts substantially differed in terms of patient characteristics. Moreover, the cohort differences model indicated statistically significant differences between the cohorts. Neither LASSO nor any of the tested classifiers resulted in a clinical relevant prognostic model that could be validated on the available datasets. CONCLUSION: The results imply that the study might have been influenced by a limited sample size, heterogeneous patient characteristics, and inconsistent imaging parameters. No prognostic performance of FDG-PET or CT based radiomics models can be reported. This study highlights the necessity of extensive evaluations of cohorts and of validation datasets, especially in retrospective multi-centric datasets. Public Library of Science 2019-06-03 /pmc/articles/PMC6546238/ /pubmed/31158263 http://dx.doi.org/10.1371/journal.pone.0217536 Text en © 2019 van Timmeren et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
van Timmeren, Janna E.
Carvalho, Sara
Leijenaar, Ralph T. H.
Troost, Esther G. C.
van Elmpt, Wouter
de Ruysscher, Dirk
Muratet, Jean-Pierre
Denis, Fabrice
Schimek-Jasch, Tanja
Nestle, Ursula
Jochems, Arthur
Woodruff, Henry C.
Oberije, Cary
Lambin, Philippe
Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
title Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
title_full Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
title_fullStr Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
title_full_unstemmed Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
title_short Challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for NSCLC patients using FDG-PET/CT radiomics
title_sort challenges and caveats of a multi-center retrospective radiomics study: an example of early treatment response assessment for nsclc patients using fdg-pet/ct radiomics
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6546238/
https://www.ncbi.nlm.nih.gov/pubmed/31158263
http://dx.doi.org/10.1371/journal.pone.0217536
work_keys_str_mv AT vantimmerenjannae challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT carvalhosara challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT leijenaarralphth challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT troostesthergc challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT vanelmptwouter challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT deruysscherdirk challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT muratetjeanpierre challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT denisfabrice challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT schimekjaschtanja challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT nestleursula challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT jochemsarthur challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT woodruffhenryc challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT oberijecary challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics
AT lambinphilippe challengesandcaveatsofamulticenterretrospectiveradiomicsstudyanexampleofearlytreatmentresponseassessmentfornsclcpatientsusingfdgpetctradiomics